![Incredibly relevant study on immunotherapy in msi-h mCRC – Foxpaws Fauxpas](https://oncodaily.com/pub/uploads/2024/08/Pi7_Tool_kl.jpeg)
Aug 26, 2024, 20:37
Incredibly relevant study on immunotherapy in msi-h mCRC – Foxpaws Fauxpas
Foxpaws Fauxpas shared a post on X:
“Fantastic and incredibly relevant study on immunorx in msi-h mCRC from ACTREC-TMC, Tata Memorial Hospital, Mehak Trikha, Laboni Sarkar, Anant Ramaswamy, and Prof Vikas Ostwal
Nivo at 20 mg and 40 mg. Crazy trailblazing.
Dr Amol Akhade– thoughts.“
Authors: Mehak Trikha, Laboni Sarkar, Aditya Dhanawat, Noorzia Syed, Himanshu Gujarathi, Manan Vora, A Sree Sivakumar Raja, Prabhat Bhargava, Anant Ramaswamy, Sarika Mandavkar, Avanish Saklani, Rajiv Kumar Kaushal, Munita Bal, Omshree Shetty, Subhash Yadav, and Vikas Ostwal.
Source: Foxpaws Fauxpas/X